Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Regulatory Filings 2021

Nov 10, 2021

3535_rns_2021-11-10_553a149e-c95c-4837-9298-73c408593b3f.html

Regulatory Filings

Open in viewer

Opens in your device viewer

Aqua Bio Technology ASA: Restorsea is being launched in South Korea

Aqua Bio Technology ASA: Restorsea is being launched in South Korea

10.11.2021 15:58:38 CET | Aqua Bio Technology ASA | Non-regulatory press

releases

Restorsea is now launching several of its products, which are based on ABT's

hatching fluid ingredient (Aquabeautine XL), in South Korea -

https://www.edaily.co.kr/news/read?newsId=01748246629244080&mediaCodeNo=257. The

Restorsea products are initially launched online in Shilla IPARK Duty Free Shop

- https://store.shillaipark.com/comm/en/en/dfhMain.dfs, the world's largest

downtown duty-free store. South Korea is one of the top 10 beauty markets in the

world, representing nearly 2.8 percent of the global market and it is known that

it is a long process to have cosmetic products successfully registered in South

Korea. The Korean cosmetics industry is said to be years ahead of the western

market, offering products that consumers can't find from North American brands.

ABT has previously announced in 2021 that Restorsea has entered into license

agreements with Nasdaq listed Hydrafacial launched -

https://hydrafacial.com/brand/restorsea/and LifeMD - https://lifemd.com/.

The positive trend from Restorsea's commercialization of ABT's proprietary

technology, increases the likelihood that ABT will receive additional renewal

payments and increased revenue from the sale of ingredients and royalties from

Restorsea and its licensees.

***

For further information, please contact CEO Håvard Lindstrøm mobile phone +47

941 32 288.

Aqua Bio Technology is developing and commercializing sustainable biotechnology

for use in skincare products. ABT's cosmetics ingredients are highly effective

and they provide the cosmetics industry with natural alternatives to traditional

ingredients. ABT is also marketing and distributing natural skincare products

developed by partners towards consumers and professional users. ABT's focus on

commercialization and development of natural ingredients and natural skincare

products has been, and will continue to be, an important part of the Company's

strategy going forward. Aqua Bio Technology is listed on the Euronext Expand

market of the Oslo Stock Exchange.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/954/1257/Download%20announcement%

20as%20PDF.pdf